Ceo Of Flexion Therapeutics Mike Clayman Talks Zilretta Phase 3 Trial
The Watch List

16 Apr 2020

ON AIR
7:00 am
Futures

Get Market Minute

Daily insights for every investor

FOLLOW US

Ceo Of Flexion Therapeutics Mike Clayman Talks Zilretta Phase 3 Trial
The Watch List

16 Apr 2020